Phenobarbitone-induced	phenobarbitone-induced	O	O	O	O
enlargement	enlargement	O	O	OTHERS	I
of	of	O	O	OTHERS	I
the	the	O	O	OTHERS	I
liver	liver	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
:	:	O	O	O	O
its	its	O	O	O	O
relationship	relationship	O	O	O	O
to	to	O	O	O	O
carbon	carbon	O	O	OTHERS	I
tetrachloride-induced	tetrachloride-induced	O	O	O	O
cirrhosis	cirrhosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
yield	yield	O	O	O	O
of	of	O	O	O	O
severe	severe	O	O	O	O
cirrhosis	cirrhosis	O	DISEASE	OTHERS	I
of	of	O	O	OTHERS	I
the	the	O	O	OTHERS	I
liver	liver	O	O	OTHERS	I
(	(	O	O	O	O
defined	defined	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
shrunken	shrunken	O	O	O	O
finely	finely	O	O	O	O
nodular	nodular	O	O	O	O
liver	liver	O	O	O	O
with	with	O	O	O	O
micronodular	micronodular	O	O	O	O
histology	histology	O	O	O	O
,	,	O	O	O	O
ascites	ascites	O	DISEASE	OTHERS	I
greater	greater	O	O	O	O
than	than	O	O	O	O
30	30	O	O	O	O
ml	ml	O	O	O	O
,	,	O	O	O	O
plasma	plasma	O	O	O	O
albumin	albumin	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
2.2	2.2	O	O	O	O
g/dl	g/dl	O	O	O	O
,	,	O	O	O	O
splenomegaly	splenomegaly	O	O	OTHERS	I
2	2	O	O	O	O
-	-	O	O	O	O
3	3	O	O	O	O
times	times	O	O	O	O
normal	normal	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
testicular	testicular	O	O	O	O
atrophy	atrophy	O	DISEASE	OTHERS	I
approximately	approximately	O	O	O	O
half	half	O	O	O	O
normal	normal	O	O	O	O
weight	weight	O	O	O	O
)	)	O	O	O	O
after	after	O	O	O	O
12	12	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
carbon	carbon	CHEMICALS	O	OTHERS	I
tetrachloride	tetrachloride	CHEMICALS	O	OTHERS	I
given	given	O	O	O	O
intragastrically	intragastrically	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
phenobarbitone-primed	phenobarbitone-primed	O	O	O	O
rat	rat	O	O	O	O
was	was	O	O	O	O
increased	increased	O	O	O	O
from	from	O	O	O	O
25	25	O	O	O	O
%	%	O	O	O	O
to	to	O	O	O	O
56	56	O	O	O	O
%	%	O	O	O	O
by	by	O	O	O	O
giving	giving	O	O	O	O
the	the	O	O	O	O
initial	initial	O	O	O	O
"	"	O	O	O	O
calibrating	calibrating	O	O	O	O
"	"	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
carbon	carbon	CHEMICALS	O	OTHERS	I
tetrachloride	tetrachloride	CHEMICALS	O	OTHERS	I
at	at	O	O	O	O
the	the	O	O	O	O
peak	peak	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
phenobarbitone-induced	phenobarbitone-induced	O	O	O	O
enlargement	enlargement	O	O	OTHERS	I
of	of	O	O	OTHERS	I
the	the	O	O	OTHERS	I
liver	liver	O	O	OTHERS	I
.	.	O	O	O	O

At	at	O	O	O	O
this	this	O	O	O	O
point	point	O	O	O	O
it	it	O	O	O	O
was	was	O	O	O	O
assumed	assumed	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
cytochrome	cytochrome	O	O	O	O
P450/CCl4	p450/ccl4	O	O	O	O
toxic	toxic	O	O	O	O
state	state	O	O	O	O
was	was	O	O	O	O
both	both	O	O	O	O
maximal	maximal	O	O	O	O
and	and	O	O	O	O
stable	stable	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
optimal	optimal	O	O	O	O
rat	rat	O	O	O	O
size	size	O	O	O	O
to	to	O	O	O	O
begin	begin	O	O	O	O
phenobarbitone	phenobarbitone	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
determined	determined	O	O	O	O
as	as	O	O	O	O
100	100	O	O	O	O
g	g	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
this	this	O	O	O	O
size	size	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
group	group	O	O	O	O
had	had	O	O	O	O
a	a	O	O	O	O
mean	mean	O	O	O	O
maximum	maximum	O	O	O	O
relative	relative	O	O	O	O
liver	liver	O	O	O	O
weight	weight	O	O	O	O
increase	increase	O	O	O	O
47	47	O	O	O	O
%	%	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
normal	normal	O	O	O	O
rats	rats	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
body	body	O	DISEASE	OTHERS	I
weight	weight	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
optimal	optimal	O	O	O	O
time	time	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
initial	initial	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
carbon	carbon	CHEMICALS	O	OTHERS	I
tetrachloride	tetrachloride	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
after	after	O	O	O	O
14	14	O	O	O	O
days	days	O	O	O	O
on	on	O	O	O	O
phenobarbitone	phenobarbitone	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

